-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Biomarkers of misfolded proteins are found
Professor Klaus Gerwert said: "Our goal is to determine the risk of developing Alzheimer's in the later stages through simple blood tests before toxic plaques form in the brain to ensure that treatment
The research team recently published the results
Early detection of asymptomatic people at high risk of Dementia
The researchers analyzed the plasma of participants in the Esther study conducted in Saar to look for potential Alzheimer's biomarkers
The current study compared 68 people diagnosed with Alzheimer's disease in a 17-year follow-up with 240 controls who were not diagnosed with Alzheimer's disease
The immune infrared sensor correctly identified 68 test subjects who eventually developed Alzheimer's
Klaus Gervoort summarizes the results of this comparative study: "However, unlike the clinical stage, this marker is not applicable to the asymptomatic early stages
Still, by combining amyloid misfolding with GFAP concentrations, the researchers were able to improve the accuracy